Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Pemetrexed & Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma), Pemetrexed is approved by the FDA for maintenance therapy and second‑ to third‑line therapy as a single agent in patients with advanced Non-small-cell lung cancer (NSCLC) (Non-squamous Cell Carcinoma) whose disease has not progressed after platinum‑based chemotherapy (1, 2, 4, 5, 6).
EMA has granted marketing authorization for pemetrexed for the treatment of advanced [Non-small-cell lung cancer (NSCLC) (Non-squamo…